BARBARA DEPRIEST: Open Payments
NPI 1497006175 · LONGMONT, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$578 in 32 payments from 12 companies in 2025. Trend: 2023 $873 · 2024 $829 · 2025 $578
Food & beverage: $578
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $122 |
| Sequel Med Tech, LLC | 3 | $65 |
| BETA BIONICS, INC. | 4 | $64 |
| Mannkind Corporation | 4 | $63 |
| SANOFI-AVENTIS U.S. LLC | 3 | $59 |
| Lilly USA, LLC | 3 | $57 |
| Tandem Diabetes Care, Inc. | 2 | $34 |
| Insulet Corporation | 2 | $30 |
| Amgen Inc. | 2 | $28 |
| Amphastar Pharmaceuticals, Inc. | 1 | $21 |
Products named: TWIIST, iLet Bionic Pancreas, AFREZZA, TZIELD, t:slim X2 Insulin Pump with Control-IQ, Omnipod, TEPEZZA, ZEPBOUND.
Industry payments across CO — which companies pay providers there.
